Elevance Health's stock price surged 6.22% in the pre-market trading session on Thursday. The healthcare insurer's shares rose following the company's better-than-expected quarterly earnings report.
Elevance Health reported a fourth-quarter adjusted profit of $3.84 per share, exceeding Wall Street analysts' estimates of $3.80 per share. The company's earnings beat was driven by lower-than-anticipated medical costs for its members during the quarter.
Furthermore, Elevance Health's total revenue for the quarter reached $45.44 billion, surpassing analysts' expectations of $44.92 billion. The company's strong revenue growth was supported by increased demand for its healthcare services.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。